NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email BOSTON, June 02, 2025–HBR debuts executive-tier offering amid rising leadership pressures, in partnership with Egon Zehnder.Read More